Cargando…
Identification and Characterization of Novel CFTR Potentiators
There is still a high unmet need for the treatment of most patients with cystic fibrosis (CF). The identification and development of new Cystic Fibrosis Transmembrane conductance Regulator (CFTR) modulators is necessary to achieve higher clinical benefit in patients. In this report we describe the c...
Autores principales: | Gees, Maarten, Musch, Sara, Van der Plas, Steven, Wesse, Anne-Sophie, Vandevelde, Ann, Verdonck, Katleen, Mammoliti, Oscar, Hwang, Tzyh-Chang, Sonck, Kathleen, Stouten, Pieter, Swensen, Andrew M., Jans, Mia, Van der Schueren, Jan, Nelles, Luc, Andrews, Martin, Conrath, Katja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212544/ https://www.ncbi.nlm.nih.gov/pubmed/30416447 http://dx.doi.org/10.3389/fphar.2018.01221 |
Ejemplares similares
-
Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators
por: de Wilde, Gert, et al.
Publicado: (2019) -
A common mechanism for CFTR potentiators
por: Yeh, Han-I, et al.
Publicado: (2017) -
Identifying the molecular target sites for CFTR potentiators GLPG1837
and VX-770
por: Yeh, Han-I, et al.
Publicado: (2019) -
Pharmacological Responses of the G542X-CFTR to CFTR Modulators
por: Fang, Xinxiu, et al.
Publicado: (2022) -
Modulation of CFTR gating by permeant ions
por: Yeh, Han-I, et al.
Publicado: (2015)